Twist Bioscience Corp
NASDAQ:TWST

Watchlist Manager
Twist Bioscience Corp Logo
Twist Bioscience Corp
NASDAQ:TWST
Watchlist
Price: 46.65 USD -3.05%
Market Cap: $2.9B

Wall Street
Price Targets

TWST Price Targets Summary
Twist Bioscience Corp

Wall Street analysts forecast TWST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TWST is 48.35 USD with a low forecast of 36.36 USD and a high forecast of 60.9 USD.

Lowest
Price Target
36.36 USD
22% Downside
Average
Price Target
48.35 USD
4% Upside
Highest
Price Target
60.9 USD
31% Upside
Twist Bioscience Corp Competitors:
Price Targets
ZEAL
Zealand Pharma A/S
80% Upside
ACIU
AC Immune SA
196% Upside
CALM
Cal-Maine Foods Inc
5% Upside
RCKT
Rocket Pharmaceuticals Inc
148% Upside

Revenue
Forecast

56% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
56% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 8 years the compound annual growth rate for Twist Bioscience Corp's revenue is 56%. The projected CAGR for the next 3 years is 16%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TWST's stock price target?
Price Target
48.35 USD

According to Wall Street analysts, the average 1-year price target for TWST is 48.35 USD with a low forecast of 36.36 USD and a high forecast of 60.9 USD.

What is Twist Bioscience Corp's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Twist Bioscience Corp's revenue is 56%. The projected CAGR for the next 3 years is 16%.

Back to Top